Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters
- PMID: 8786705
- DOI: 10.1016/0024-3205(96)00052-5
Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters
Abstract
We have synthesized several derivative of dl-threo-methylphenidate (Ritalin) bearing substituents on the phenyl ring. IC50 values for binding these compounds to rat brain monoamine transporters were assessed using [3H]WIN 35,428 (striatal membranes, dopamine transporters, DAT), [3H]nisoxetine (frontal cortex membranes, norepinephrine transporters, NET) and [3H]paroxetine (brain stem membranes, 5HT transporters, 5HTT). Affinities (1/Ki) decreased in the order: DAT > NET >> 5HTT. Substitution at the para position of dl-threo-methylphenidate generally led to retained or increased affinity for the dopamine transporter (bromo > iodo > methoxy > hydroxy). Substitution at the meta position also increased affinity for the DAT (m-bromo > methylphenidate; m-iodo-p-hydroxy > p-hydroxy). Substitution at the ortho position with bromine considerably decreased affinity. Similar IC50 values for binding of o-bromomethylphenidate to the dopamine transporter were measured at 0, 22 and 37 degrees. N-Methylation of the piperidine ring of methylphenidate also considerably reduced affinity. The dl-erythro isomer of o-bromomethylphenidate did not bind to the DAT (IC50 > 50,000 nM). Affinities at the dopamine and norepinephrine transporters for substituted methylphenidate derivatives were well correlated (r2=0.90). Abilities of several methylphenidate derivatives to inhibit [3H]dopamine uptake in striatal synaptosomes corresponded well with inhibition of [3H]WIN 35, 428 binding. None of the compounds examined exhibited significant affinity to dopamine D1 or D2 receptors (IC50 > 500 or 5,000 nM, respectively), as assessed by inhibition of binding of [3H]SCH 23390 or [123I]epidepride, respectively, to striatal membranes.
Similar articles
-
Binding of bromine-substituted analogs of methylphenidate to monoamine transporters.Eur J Pharmacol. 1994 Oct 24;264(2):177-82. doi: 10.1016/0014-2999(94)00460-9. Eur J Pharmacol. 1994. PMID: 7851480
-
Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.J Med Chem. 2003 May 22;46(11):2205-15. doi: 10.1021/jm020561w. J Med Chem. 2003. PMID: 12747792
-
Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.J Med Chem. 2004 Oct 7;47(21):5101-13. doi: 10.1021/jm049796t. J Med Chem. 2004. PMID: 15456254
-
Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.J Med Chem. 2001 Mar 15;44(6):937-48. doi: 10.1021/jm000311k. J Med Chem. 2001. PMID: 11300876
-
Advances in sodium-ion coupled biogenic amine transporters.Life Sci. 1992;51(9):631-45. doi: 10.1016/0024-3205(92)90236-i. Life Sci. 1992. PMID: 1501510 Review.
Cited by
-
Influence of methylphenidate on brain development--an update of recent animal experiments.Behav Brain Funct. 2006 Jan 10;2:2. doi: 10.1186/1744-9081-2-2. Behav Brain Funct. 2006. PMID: 16403217 Free PMC article.
-
PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.Pharmacogenet Genomics. 2019 Aug;29(6):136-154. doi: 10.1097/FPC.0000000000000376. Pharmacogenet Genomics. 2019. PMID: 30950912 Free PMC article. Review. No abstract available.
-
Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain.Anesth Analg. 2020 Feb;130(2):518-524. doi: 10.1213/ANE.0000000000004273. Anesth Analg. 2020. PMID: 31206430 Free PMC article.
-
Effects of methylphenidate on the aggressive behavior, serotonin and dopamine levels, and dopamine-related gene transcription in brain of male Nile tilapia (Oreochromis niloticus).Fish Physiol Biochem. 2019 Aug;45(4):1377-1391. doi: 10.1007/s10695-019-00645-2. Epub 2019 May 3. Fish Physiol Biochem. 2019. PMID: 31054043
-
Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT.Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):694-701. doi: 10.1007/s00259-010-1668-x. Epub 2010 Nov 26. Eur J Nucl Med Mol Imaging. 2011. PMID: 21110190
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous